All News | FDA

Advertising & Promotion

Aug 16, 2018
Study Finds Online Ads Are as Effective as TV Ads in Getting Consumers to ‘Ask their Doctor’
Aug 15, 2018
Former Pharma Sales Rep Indicted for Alleged Role in Scheme To Defraud Health Insurers
Aug 15, 2018
OPDP Research on Risk Information in DTC Print Ads Moves Forward
Aug 15, 2018
New York State Files Lawsuit Against Purdue
Aug 14, 2018
Can PROs Be Used in Promotion?
Aug 9, 2018
OPDP Moves Ahead with Disclosure Research
Aug 9, 2018
Insys Reaches Agreement in Principle in DOJ Probe of Sales Practices
Aug 8, 2018
AstraZeneca Agrees To Pay Texas $110 Million Over Crestor, Seroquel Marketing
Aug 7, 2018
New Jersey Looks To Change Meal Rules
Aug 3, 2018
House Committee Asks Three Opioid Manufacturers About Their Sales Practices

Good Clinical Practice

Oct 31, 2018
Public Citizen Calls for Suspension of Minnesota IRB
Oct 31, 2018
NHLBI Pauses Trial Over Science Behind It
Oct 30, 2018
UK Panel Recommends Ways To Improve Clinical Trial Result Reporting
Oct 30, 2018
FDA Wants Comments on Surrogate Endpoint Table
Oct 29, 2018
NIH Releases Flyer Explaining Clinical Studies
Oct 26, 2018
Former SACHRP Chair: COI Violations Should Be Considered Research Misconduct
Oct 25, 2018
Study Finds FDAAA Helped Increase Trial Registration and Results Reporting
Oct 25, 2018
Pa. Gov. Signs Bill Allowing Travel Reimbursement for Cancer Trials
Oct 25, 2018
Novel Analytics Used To Deal with Missing Lupus Study Data
Oct 23, 2018
Alzheimer’s Group Starts Two Projects To Aid Research

U.S. Food Labeling

FDA Regulation & Enforcement

Nov 21, 2021
FSIS Extends Comment Period on Labeling Cell Cultured Meat, Poultry
Nov 19, 2021
Oregon Sues Endo Over Opioid Marketing
Nov 18, 2021
Biden Nominates Dr. Robert Califf To Head the FDA Again as Commissioner of Food and Drugs
Nov 18, 2021
Pharma Company To Pay Over $12.7 Million To Resolve False Claims Allegations Related to Overdose Drug
Nov 14, 2021
OPDP Researchers Plan Second Look at Proprietary Names
Nov 11, 2021
Department of Health and Human Services OIG Updates Health Care Fraud Self-Disclosure Protocol
Nov 10, 2021
FDA Revises Temporary Marketing Permit Guidance To Streamline Process
Nov 6, 2021
California, Oklahoma Courts Find for Manufacturers in Opioid Marketing Cases
Nov 3, 2021
DOJ Toughens Prosecution Policies on Disclosing Responsible Individuals, Past Corporate Violations
Nov 1, 2021
Florida Device Firm Pleads Guilty to Dealing in Unapproved HA Devices, Agrees to Forfeiture

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.